Log in to save to my catalogue

ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutation...

ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutation...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7459315

ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutations: implication for the two-hit hypothesis

About this item

Full title

ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutations: implication for the two-hit hypothesis

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2020-08, Vol.10 (1), p.14260-14260, Article 14260

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

ARID1A
loss-of-function mutation accompanied by a loss of ARID1A protein expression is considered one of the most important driver events in endometriosis-associated ovarian cancer. Although our recent genomic study clarified that
ARID1A
loss-of-function mutations were detected in 13% of ovarian endometriosis, an association between the

Alternative Titles

Full title

ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutations: implication for the two-hit hypothesis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7459315

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7459315

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-020-71273-7

How to access this item